Ignite Creation Date:
2025-12-25 @ 1:38 AM
Ignite Modification Date:
2026-01-25 @ 3:19 AM
Study NCT ID:
NCT01608594
Status:
COMPLETED
Last Update Posted:
2018-08-28
First Post:
2012-05-26
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Neoadjuvant Combination Therapy With Ipilimumab and HighDose IFN-α2b for Melanoma
Sponsor:
Diwakar Davar
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
11-063
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None